Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
The International Vaccine Institute (IVI) and the Korea Disease Control and Prevention Agency (KDCA), together with four...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of d...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Galux, a South Korean biotech startup pioneering AI-driven protein therapeutics discovery, has signed a research agreeme...
MEDI&GENE, a South Korea-based biopharmaceutical company developing therapeutics for metabolic diseases, has entered...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
ADEL, Inc., a South Korea-based biopharmaceutical company dedicated to developing therapies for neurodegenerative diseas...
